Get started
Author

Isabelle Van Praagh-Doreau

Observed names: I. Van Praagh-Doreau, I. van Praagh-Doreau, Isabelle van Praagh-Doreau, Van Praagh-Doreau, I.
Institution: Centre Jean Perrin
OpenAlex ID: A5088999457
Long term improved quality of life by a 2-week group physical and educational intervention shortly after breast cancer chemotherapy completion. Results of the ‘Programme of Accompanying women after breast Cancer treatment completion in Thermal resorts’ (PACThe) randomised clinical trial of 251 patients
2013 · F. Kwiatkowski, M.A. Mouret-Reynier, et al. · European Journal of Cancer · 71
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial
2010 · Etienne G.C. Brain, Cécile Mertens, et al. · Critical Reviews in Oncology/Hematology · 55
Long-term improvement of breast cancer survivors’ quality of life by a 2-week group physical and educational intervention: 5-year update of the ‘PACThe’ trial
2017 · Fabrice Kwiatkowski, Marie-Ange Mouret-Reynier, et al. · British Journal of Cancer · 38
PDF
Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial
2018 · Pierre-Etienne Heudel, Isabelle Van Praagh-Doreau, et al. · Supportive Care in Cancer · 25
Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program
2019 · Laure Vacher, Emilie Thivat, et al. · Supportive Care in Cancer · 17
Panitumumab in combination with FEC 100 (5-fluorouracil, epidoxorubicin, cyclophosphamide) followed by docetaxel (T) in patients with operable, triple-negative breast cancer (TNBC): Preliminary results of a multicenter neoadjuvant pilot phase II study.
2011 · J. Nabholtz, B. Weber, et al. · Journal of Clinical Oncology · 17
Effectiveness of a Global Multidisciplinary Supportive and Educational Intervention in Thermal Resort on Anthropometric and Biological Parameters, and the Disease-Free Survival after Breast Cancer Treatment Completion (PACThe)
2020 · Marie-Paule Vasson, Fabrice Kwiatkowski, et al. · Journal of Oncology · 9
PDF
Chimioradiothérapie concomitante des cancers du sein inflammatoire, non métastatiques, non répondeurs à une chimiothérapie première
2015 · A. Bellière-Calandry, C. Benoît, et al. · Cancer/Radiothérapie · 3
Survie globale (SG) et survie sans rechute (SSR) dans différents sous-groupes de cancers du sein : luminal A, luminal B, triple négatifs et Her2+, traités par chimiothérapie néoadjuvante (CTNA)
2012 · C. Abrial, M.-M. Dauplat, et al. · Annales de Pathologie · 1
Long-Term Overall Survival (OS) and Disease-Free Survival (DFS) According to PCR in Breast Cancers Subtypes: Luminal A and B, Triple Negative and HER2 +, Treated by Neaodjuvant Chemotherapy (NCT)
2012 · C. Abrial, Q. Wang-Lopez, et al. · Annals of Oncology · 1
Neoadjuvant chemotherapy (NCT) in operable HR-positive and TN breast cancer (BC): A randomized study comparing standard schedule to response-adapted sequence.
2010 · C. Jouannaud, J. Charpentier, et al. · Journal of Clinical Oncology · 1
[Breast tumours].
2013 · Sylvie Lemery, Isabelle Van Praagh-Doreau · PubMed
Pathologic complete response (pCR) to predict patients’ survival in luminal breast cancer.
2013 · Qian Wang-Lopez, Fabrice Kwiatkowski, et al. · Journal of Clinical Oncology
Chimioradiothérapie concomitante des cancers du sein inflammatoire non métastatiques inopérables après échec d’une chimiothérapie première
2012 · A. Bellière-Calandry, C. Benoît, et al. · Cancer/Radiothérapie
Pathologic response rate for high-risk operable breast cancer after TNCF semi-intensive neoadjuvant chemotherapy: Updated data with long-term results.
2010 · X. Durando, H. Cure, et al. · Journal of Clinical Oncology
Neoadjuvant chemotherapy (NCT) in 466 patients for operable breast cancer: Predictive factors for pathological response.
2010 · C. Abrial, X. Durando, et al. · Journal of Clinical Oncology
0182 Concomitant radio-chemotherapy (RCT) in inflammatory breast cancer (IBC) non responsive to primary chemotherapy (CT)
2009 · I. Van Praagh-Doreau, L. Calvet, et al. · The Breast
Works count: 18
Citation count: 238
H-index: 7
I10-index: 6
Year
Topic
Type